National pre-settlement funding provider continues strategic focus on late-stage, mid-stage, and emerging pharmaceutical and medical device litigation JERSEY CITY, N.J., March 5, 2026 /PRNewswire/ -- ...
Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive valid, exclusive mass tort cases. Our program is built on a ‘Medical-First’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results